Neogenomics Inc’s recent filing unveils that its EVP, GC & Business Development Olivo Alicia C unloaded Company’s shares for reported $0.25 million on Nov 25 ’25. In the deal valued at $12.00 per share,20,916 shares were sold. As a result of this transaction, Olivo Alicia C now holds 31,083 shares worth roughly $0.39 million.
Then, ALICIA OLIVO bought 11,939 shares, generating $138,612 in total proceeds.
Before that, ALICIA OLIVO bought 4,918 shares. Neogenomics Inc shares valued at $49,032 were divested by the Officer at a price of $9.97 per share.
BTIG Research downgraded its Neogenomics Inc [NEO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Mkt perform”. Guggenheim began covering NEO with “Neutral” recommendation on May 15, 2025. Leerink Partners revised its rating on April 30, 2025. It rated NEO as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of NEO
On Monday, Neogenomics Inc [NASDAQ:NEO] saw its stock fall -5.09% to $12.49. Over the last five days, the stock has gained 3.39%. Neogenomics Inc shares have fallen nearly -32.89% since the year began. Nevertheless, the stocks have risen 6.21% over the past one year.
How much short interest is there in Neogenomics Inc?
A steep rise in short interest was recorded in Neogenomics Inc stocks on 2025-12-31, dropping by -1.19 million shares to a total of 7.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 9.05 million shares. There was a decline of -15.08%, which implies that there is a negative sentiment for the stock.
